PATH Drug Solutions
Seattle, Washington, United States
Purpose
to conduct due diligence on Tribendimidine (an approved Chinese drug against hookworm infection), and to prepare a product development proposal to develop TBD, with the goal towards submission to and approval by a Western regulatory agency
Division
Global Health
Date
March 2008
Region Served
AFRICA, AMERICA, ASIA
Committed amount
$748,323
Grant topic
Enteric and Diarrheal Diseases
Duration (months)
53
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.